Advances in the Pharmacologic Study of Ribavirin 
Co-administration

Xuyuan Zhang; Kaiyuan Fu

doi:10.70711/mhr.v2i5.6273

Advances in the Pharmacologic Study of Ribavirin Co-administration

Xuyuan Zhang, Kaiyuan Fu

Abstract

This article summarizes the research progress of ribavirin combination for the treatment of viral pneumonia and bronchitis caused
by respiratory syncytial virus, cutaneous herpesvirus, and hepatitis C virus, and analyzes the effect of some combinations on adverse reactions, which can provide a reference for ribavirin combination.

Keywords

Ribavirin; Coadministration; Virus; Adverse effects

Full Text:

PDF

Included Database

References

[1] Zheng PY. Clinical efficacy study of buspirone anti-inflammatory oral solution combined with ribavirin in the treatment of pediatric upper respiratory tract viral infections[J]. Heilongjiang Traditional Chinese Medicine, 2023, 52(05):397-399.

[2] Wang Jianjiao, Zhu Yinhua. Clinical efficacy of fosbutinide combined with ribavirin in children with capillary bronchiolitis[J]. Tibetan

Medicine, 2024, 45(03):78-79.

[3] Lan Wenjing, Li Feng, Ma Miaomiao. Effectiveness of loratadine combined with pidomod adjuvant ribavirin in the treatment of recurrent respiratory tract infections[J]. Chinese Journal of Drug Abuse Prevention and Control, 2024, 30(04):718-720+729.

[4] Shang Ning, An Ping, Bian Li. Effect of protonixa combined with ribavirin tablets in the treatment of hepatitis C cirrhosis in the decompensated stage[J]. China Practical Medicine, 2021, 16(23):130-132.

[5] Du Hejuan, Jiang Yiming, Yang Qi'en, et al. Clinical study of polyethylene glycol interferon alpha-2a injection combined with ribavirin

tablets for the treatment of viral hepatitis C cirrhosis after splenic embolization[J]. Chinese Journal of Clinical Pharmacology, 2017,

33(16):1523-1526.

[6] Ou Shuyu, Qiao Zhikun. Efficacy and safety evaluation of recombinant human interferon alpha-1b combined with ribavirin tablets in the

treatment of chronic hepatitis C[J]. Journal of Clinical Rational Drug Use, 2014, 7(06):44-45.

[7] Dong Nanxiu. Clinical effect of combining ribavirin with diarrhea and yellow powder in the treatment of herpes pharyngitis in children

with accumulated heat in the heart and spleen[J]. Journal of Clinical Rational Use of Drugs, 2022, 15(31):133-135.

[8] Wu Fangchun, Zhang Feifei, Wu Haijie. Clinical study on pediatric herpes pharyngitis treated with ribavirin in combination with pediatric Diao Qiao Qing Hei Granules[J]. New Chinese Medicine, 2021, 53(01):94-97.

[9] He Jin'e, Li Jia, Wang Wei, et al. Clinical study of pediatric compound amino acids combined with ribavirin in the treatment of pediatric

herpes pharyngitis[J]. China Medicine Herald, 2020, 17(02):152-155.

[10] Li Weijian, Li Ying, Lin Changyu. Observations on the efficacy and adverse reactions of polyethylene glycol interferon alpha-2a combined with ribavirin in the treatment of chronic viral hepatitis C[J]. China Practical Medicine, 2015, 10(13):140-141.

[11] Zhu Xue, Wang Jing. Observation on the efficacy and adverse reactions of polyethylene glycol interferon alpha-2a combined with ribavirin in the treatment of chronic hepatitis C[J]. China Prescription Drugs, 2015, 13(09):80-81.

[12] Chen Hongbo, Zhang Yongfeng, Wang Yifan, et al. Observations on the efficacy and adverse reactions of interferon combined with ribavirin in the treatment of chronic hepatitis C[J]. Chinese and foreign medical research, 2015, 13(35):50-52.

DOI: http://dx.doi.org/10.70711/mhr.v2i5.6273

Refbacks

There are currently no refbacks.